Demand for Remicade Biosimilar in USA Growth, Tren..

oprettet en ny artikel

21 timer

Demand for Remicade Biosimilar in USA Growth, Trends, Company Profiles, Market Share Analysis By FMI | #demand for Remicade Biosimilar in USA

Demand for Remicade Biosimilar in USA Growth, Trends, Company Profiles, Market Share Analysis By FMI

Demand for Remicade Biosimilar in USA Growth, Trends, Company Profiles, Market Share Analysis By FMI

The U.S. Remicade biosimilar market is valued at USD 0.8 billion in 2025 and is projected to expand to USD 1.4 billion by 2035, registering a compound annual growth rate (CAGR) of 5.1% over the forecast period.

Synes godt om

Kommentar

Del